TY - JOUR
T1 - Bone Marrow Adiposity Alterations in Postmenopausal Women with Type 2 Diabetes Are Site-Specific
AU - Badr, Sammy
AU - Cotten, Anne
AU - Lombardo, Daniela
AU - Ruschke, Stefan
AU - Karampinos, Dimitrios C.
AU - Ramdane, Nassima
AU - Genin, Michael
AU - Paccou, Julien
N1 - Publisher Copyright:
© 2024 The Author(s). Published by Oxford University Press on behalf of the Endocrine Society.
PY - 2024/11/1
Y1 - 2024/11/1
N2 - Context: Bone marrow adiposity (BMAT) alterations in patients with type 2 diabetes mellitus (T2DM) may contribute to adverse bone effects. Objective: Characterization of BMAT content and composition in patients with well-controlled T2DM. Methods: This cross-sectional study included 2 groups of postmenopausal women: one with T2DM and the other without. The proton density fat fraction (PDFF) of the lumbar spine and proximal femur, comprising the femoral head, neck, and diaphysis, was assessed using chemical shift-based water-fat separation imaging (WFI). Magnetic resonance imaging with spectroscopy (1H-MRS) was performed in a subgroup of participants to confirm the PDFF measurements and determine the apparent lipid unsaturation level (aLUL) at the L3 vertebrae and femoral neck. The association of imaging-based PDFFs and aLUL between diabetes groups was investigated by adjusting for confounding factors using a linear mixed model. Results: Among 199 participants, patients with T2DM (n = 29) were significantly heavier (P <. 001) and had a higher bone mineral density (BMD) (P <. 001 for all sites) than nondiabetic patients (n = 170). When PDFFs were compared after adjusting for age, body mass index (BMI), and BMD, the femoral head WFI-based PDFF was lower in patients with T2DM (mean [standard error] 88.0% [0.7] vs 90.6% [0.3], P <. 001). Moreover, the aLUL at the L3 vertebrae was lower in patients with T2DM (n = 16) than in without (n = 97) (mean [standard error] 3.9% [0.1] vs 4.3% [0.1], P =. 02). Conclusion: The content and composition of BMAT are modified in postmenopausal women with T2DM and these changes occur at specific sites.
AB - Context: Bone marrow adiposity (BMAT) alterations in patients with type 2 diabetes mellitus (T2DM) may contribute to adverse bone effects. Objective: Characterization of BMAT content and composition in patients with well-controlled T2DM. Methods: This cross-sectional study included 2 groups of postmenopausal women: one with T2DM and the other without. The proton density fat fraction (PDFF) of the lumbar spine and proximal femur, comprising the femoral head, neck, and diaphysis, was assessed using chemical shift-based water-fat separation imaging (WFI). Magnetic resonance imaging with spectroscopy (1H-MRS) was performed in a subgroup of participants to confirm the PDFF measurements and determine the apparent lipid unsaturation level (aLUL) at the L3 vertebrae and femoral neck. The association of imaging-based PDFFs and aLUL between diabetes groups was investigated by adjusting for confounding factors using a linear mixed model. Results: Among 199 participants, patients with T2DM (n = 29) were significantly heavier (P <. 001) and had a higher bone mineral density (BMD) (P <. 001 for all sites) than nondiabetic patients (n = 170). When PDFFs were compared after adjusting for age, body mass index (BMI), and BMD, the femoral head WFI-based PDFF was lower in patients with T2DM (mean [standard error] 88.0% [0.7] vs 90.6% [0.3], P <. 001). Moreover, the aLUL at the L3 vertebrae was lower in patients with T2DM (n = 16) than in without (n = 97) (mean [standard error] 3.9% [0.1] vs 4.3% [0.1], P =. 02). Conclusion: The content and composition of BMAT are modified in postmenopausal women with T2DM and these changes occur at specific sites.
KW - bone marrow adipose tissue
KW - bone mineral density
KW - diabetes mellitus
KW - glycated hemoglobin
KW - osteoporosis
UR - http://www.scopus.com/inward/record.url?scp=85206675319&partnerID=8YFLogxK
U2 - 10.1210/jendso/bvae161
DO - 10.1210/jendso/bvae161
M3 - Article
AN - SCOPUS:85206675319
SN - 2472-1972
VL - 8
JO - Journal of the Endocrine Society
JF - Journal of the Endocrine Society
IS - 11
M1 - bvae161
ER -